Current Neuro-Oncology
Volume
8 Number 9
30 September 2006
Home > Publications > Current Neuro-Oncology > Volume 8, Year 2006 > Number 9, 30 September
Packer RJ, Gajjar A, Vezina G,
Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue
BR, Marymont MH, Muraszko K, Langston J, Sposto R.
Phase
III study of craniospinal radiation therapy followed by adjuvant
chemotherapy for newly diagnosed average-risk medulloblastoma.
J
Clin Oncol. 2006 Sep 1;24(25):4202-8⍈.
doi: 10.1200/JCO.2006.06.4980⍈.
PMID: 16943538⍈.
Phase 3 trial. ⍈
Gajjar A, Chintagumpala M, Ashley
D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V,
Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF,
Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D,
Gilbertson RJ.
Risk-adapted
craniospinal radiotherapy followed by high-dose chemotherapy and
stem-cell rescue in children with newly diagnosed medulloblastoma
(St Jude Medulloblastoma-96): long-term results from a
prospective, multicentre trial.
Lancet
Oncol. 2006 Sep 7;7(10):813-20⍈.
doi: 10.1016/S1470-2045(06)70867-1⍈.
PMID: 17012043⍈.
Phase 2 trial. ⍈
Erratum
in: Lancet Oncol. 2006 Oct;7(10):797⍈.
doi: 10.1016/S1470-2045(06)70881-6⍈.
Correction. ⍈